Evidence map›Paper›PMID 22184199›Full record

ArticleThe Journal of cell biology2011

Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin.

Nadine Schmidt, Mohammed Akaaboune, Nadesan Gajendran, Isabel Martinez-Pena y Valenzuela, Sarah Wakefield, Raphael Thurnheer, Hans Rudolf Brenner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 93 citations in OpenAlex.

  1. Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. NMJ-related diseases beyond the congenital myasthenic syndromes.Frontiers in cell and developmental biology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Nadine SchmidtInstitute of Physiology, Department of Biomedicine, University of Basel, CH-4056, Basel, Switzerland.
Mohammed Akaaboune
Nadesan Gajendran
Isabel Martinez-Pena y Valenzuela
Sarah Wakefield
Raphael Thurnheer
Hans Rudolf Brenner
University of Basel · CHUniversity of Michigan–Ann Arbor · USUniversity Hospital of Basel · CH

Funding

Medical Research Council MC_U120061454
6 · The paper itself

Abstract

Neuregulin (NRG)/ErbB signaling is involved in numerous developmental processes in the nervous system, including synapse formation and function in the central nervous system. Although intensively investigated, its role at the neuromuscular synapse has remained elusive. Here, we demonstrate that loss of neuromuscular NRG/ErbB signaling destabilized anchoring of acetylcholine receptors (AChRs) in the postsynaptic muscle membrane and that this effect was caused by dephosphorylation of α-dystrobrevin1, a component of the postsynaptic scaffold. Specifically, in mice in which NRG signaling to muscle was genetically or pharmacologically abolished, postsynaptic AChRs moved rapidly from the synaptic to the perisynaptic membrane, and the subsynaptic scaffold that anchors the AChRs was impaired. These defects combined compromised synaptic transmission. We further show that blockade of NRG/ErbB signaling abolished tyrosine phosphorylation of α-dystrobrevin1, which reduced the stability of receptors in agrin-induced AChR clusters in cultured myotubes. Our data indicate that NRG/ErbB signaling maintains high efficacy of synaptic transmission by stabilizing the postsynaptic apparatus via phosphorylation of α-dystrobrevin1.

Indexed as

AgrinAnimalsCells, CulturedDystrophin-Associated ProteinsErb-b2 Receptor Tyrosine KinasesErbB ReceptorsMiceMice, KnockoutMuscle Fibers, SkeletalNeuregulinsNeuromuscular JunctionPhosphorylationReceptor, ErbB-4Receptors, CholinergicSignal TransductionSynaptic MembranesAgrindystrobrevinDystrophin-Associated ProteinsErbb2 protein, mouseErb-b2 Receptor Tyrosine KinasesErbb4 protein, mouseErbB ReceptorsNeuregulinsReceptor, ErbB-4Receptors, Cholinergic

Identifiers

PMID22184199
PMCPMC3246897
OpenAlexW2092025416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.